Systemic changes following carrageenan-induced paw inflammation in rats

Inflammation Research

Volumn 64, Issue 5, 2015, Pages 333-342

  Vazquez, E ^a   Navarro, M ^b   Salazar, Y ^a   Crespo, G ^a   Bruges, G ^a   Osorio, C ^a   Tortorici, V ^a   Vanegas, H ^a   López, Mercedes ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSIDAD DE CARABOBO   (Venezuela)

Author keywords

Carrageenan; Lung inflammation; Paw model; Proinflammatory cytokines; Tissue factor expression

Indexed keywords

C REACTIVE PROTEIN; CARRAGEENAN; CYTOKINE; FIBRINOGEN; THROMBOPLASTIN;

ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EDEMA; FOOT; INFLAMMATION; LUNG; METABOLISM; PAIN MEASUREMENT; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; C-REACTIVE PROTEIN; CARRAGEENAN; CYTOKINES; EDEMA; FIBRINOGEN; FOOT; INFLAMMATION; LUNG; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; THROMBOPLASTIN;

EID: 84939992389     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-015-0814-0     Document Type: Article

References (37)

1. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–7.
2. Di Rosa M, Giroud JP, Willoughby DA. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971;1971(104):15–29.
3. Di Rosa M, Willoughby DA. Screens for anti-inflammatory drugs. J Pharm Pharmacol. 1971;23:297–8.
4. Salvemini D, Wang ZQ, Bourdon DM, Stern MK, Currie MG, Manning PT. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur J Pharmacol. 1996;303:217–20.
5. Guay J, Bateman K, Gordon R, Mancini J, Riendeau D. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem. 2004;279:24866–72.
6. Velo GP, Dunn CJ, Giroud JP, Timsit J, Willoughby DA. Distribution of prostaglandins in inflammatory exudate. J Pathol. 1973;111:149–58.
7. Capasso F, Dunn CJ, Yamamoto S, Willoughby DA, Giroud JP. Further studies on carrageenan-induced pleurisy in rats. J Pathol. 1975;116:117–24.
8. Srivastava R, Srimal RC. Amplification of platelet response during acute inflammation in rats. Biochem Pharmacol. 1990;40:357–63.
9. Cicala C, Morello S, Alfieri A, Vellecco V, Marzocco S, Autore G. Haemostatic imbalance following carrageenan-induced rat paw oedema. Eur J Pharmacol. 2007;577:156–61.
10. Ratnoff OD, Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951;37:316–20.
11. Li D, Weng S, Yang B, Zander DS, Saldeen T, Nichols WW, Khan S, Mehta JL. Inhibition of arterial thrombus formation by ApoA1 Milano. Arterioscler Thromb Vasc Biol. 1999;19:378–83.
12. D’Suze G, Dıaz P, Salazar V, Sevcik C, Brazon J. Effect of leukocyte inhibitors benzydamine and cyclophosphamide, on lung injury caused by Tityus discrepans scorpion venom. Toxicon. 2007;50:1116–25.
13. Fehrenbacher JC, Vasko MR, Duarte DB. Models of inflammation: carrageenan- or complete Freund’s adjuvant (CFA)-induced edema and hypersensitivity in the rat. Curr Protoc Pharmacol. 2012. doi:10.1002/0471141755.ph0504s56.
14. Chavan HV, Adsul LK, Kotmale AS, Dhakane VD, Thakare VN, Bandgar BP. Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazolone-based chalcones. J Enzyme Inhib Med Chem. 2014. doi:10.3109/14756366.2013.873037.
15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88.
16. Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med. 1993;36:611–22.
17. Murata H, Shimada N, Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J. 2004;168:28–40.
18. Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res. 2005;96:714–6.
19. Cermak J, Key N, Bach R, Balla J, Jacob H, Vercellotti G. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513–20.
20. Chen Y, Wang J, Yao Y, Yuan W, Kong M, Lin Y, Geng D, Nie R. CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway. FEBS Lett. 2009;583:2811–8.
21. Wu J, Stevenson MJ, Brown JM, Grunz EA, Strawn TL, Fay WP. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler Thromb Vasc Biol. 2008;28:698–704.
22. van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 1994;179:1253–9.
23. Levi M, van der Poll T, ten Cate H, van Deventer SJ. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest. 1997;27:3–9.
24. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38:26–34.
25. Corsini E, Di Paola R, Viviani B, Genovese T, Mazzon E, Lucchi L, Marinovich M, Galli CL, Cuzzocrea S. Increased carrageenan-induced acute lung inflammation in old rats. Immunology. 2005;115:253–61.
26. Mazzon E, Esposito E, Di Paola R, Muià C, Crisafulli C, Genovese T, Caminiti R, Meli R, Bramanti P, Cuzzocrea S. Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept. Clin Exp Immunol. 2008;153:136–49.
27. Frode TS, Souza GE, Calixto JB. The modulatory role played by TNF-alpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine. 2011;13:162–8.
28. Utsunomiya I, Ito M, Oh-ishi S. Generation of inflammatory cytokines in zymosan-induced pleurisy in rats: TNF induces IL-6 and cytokine-induced neutrophil chemoattractant (CINC) in vivo. Cytokine. 1998;10:956–63.
29. Rapaport S, Rao LV. The tissue factor pathway: how it has become a “prima ballerina”. Thromb Haemost. 1995;74:7–17.
30. Chu AJ. Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit. Front Biosci. 2006;11:256–71.
31. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991;33:127–34.
32. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994;93:114–20.
33. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003;31:213–20.
34. Moraes TJ, Chow CW, Downey GP. Proteases and lung injury. Crit Care Med. 2003;31:189–94.
35. Parry G, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:612–21.
36. Mechtcheriakova D, Wlachos A, Holzmuller H, Binder BR, Hofer E. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood. 1999;93:3811–23.
37. Wiseman EH, Chang YH. The role of fibrin in the inflammatory response to carrageenin. J Pharm Exp Ther. 1968;159:206–10.